Prostate News and Research

RSS

Lifestyle changes may affect the progression of any type of cancer

Men with early stage prostate cancer who make intensive changes in diet and lifestyle may stop or perhaps even reverse the progression of their illness, according to a new study.

11 Aug 2005

FDA approval sought for Pfizer's new cancer drug

Drug company Pfizer has announced it has submitted a New Drug Application (NDA) for its cancer drug Sutent, to the U.S. Food and Drug Administration (FDA).

11 Aug 2005

New prostate cancer test could save thousands from unnecessary surgery

Doctors at present lack a test that can distinguish fast-developing tumours that need urgent attention from slow-growing ones that are not a threat and need only watching, and as a result many men have operations that can leave them impotent and incontinent for prostate tumours that would never have killed them.

10 Aug 2005

Checkerboard Tissue Microarray (TMA) Method will help in predicting the behaviour of prostate cancer

Scientists from The Institute of Cancer Research have developed a technique which will markedly help in predicting the behaviour of prostate cancer.

9 Aug 2005

Researchers identify protein called EMP-1 that is present in the tumors of patients who fail to respond to treatment with gefitinib

By the time the human genome was mapped, cancer researchers had already begun investigating the proteins that were encoded by these newly identified genes.

9 Aug 2005

Researchers use diffusion magnetic resonance imaging to monitor ultrasound uterine

Johns Hopkins researchers have, for what is believed to be the first time, used a magnetic resonance imaging (MRI) technique called diffusion-weighted MRI (DWI), a technique that images the movement, or diffusion, of water molecules in tissues, to successfully determine the effectiveness of high-intensity focused ultrasound for treating uterine fibroids.

9 Aug 2005

Scientist have found an unexpected effect of the interaction of PTEN and p53 genes in early stage prostate cancer

Prostate cancer, the second leading cause of cancer death for men in the United States, is caused by changes in several tummor suppressor genes including PTEN and p53. Up to 70 percent of men with prostate cancer have lost one copy of the PTEN gene at the time of diagnosis, and p53 is absent in a high number of patients with advanced prostate cancer.

3 Aug 2005

Lowering the current PSA threshold for recommending a prostate biopsy may subject millions of men to unnecessary, potentially harmful medical procedures

Lowering the current prostate-specific antigen (PSA) threshold for recommending a prostate biopsy may subject millions of men to unnecessary, potentially harmful medical procedures with no evidence that it will improve prostate cancer mortality rates, according to a new study in the August 3 issue of the Journal of the National Cancer Institute.

2 Aug 2005

Omega-6 fatty acids promote the growth of prostate tumor cells in the laboratory

A study conducted at the San Francisco VA Medical Center (SFVAMC) has demonstrated that omega-6 fatty acids such as the fat found in corn oil promote the growth of prostate tumor cells in the laboratory.

2 Aug 2005

Clinical factors can help predict the risk of prostate cancer death for patients following a radical prostatectomy

Clinical factors including the time to biochemical recurrence following surgery can help predict the risk of prostate cancer death for patients following a radical prostatectomy, according to a study in the July 27 issue of JAMA: The Journal of the American Medical Association.

27 Jul 2005

Rate of increase in PSA value predicts risk of death following radiation therapy

Men who have a higher rate of increase in their PSA value in the year prior to their prostate cancer diagnosis have a significantly higher risk of death following radiation therapy, according to a study in the July 27 issue of JAMA: The Journal of the American Medical Association.

26 Jul 2005

Tool helps determine who is at high risk of death after prostate cancer recurrence following surgery

Researchers at Johns Hopkins and The Brady Urological Institute have identified three risk factors and developed a simple reference tool that doctors can use to determine who is at high risk of death after prostate cancer recurrence following surgery.

26 Jul 2005

Cancer vaccine combined with hormone-deprivation therapy can help patients with recurrence of prostate cancer

A new study finds that a cancer vaccine combined with hormone-deprivation therapy can help patients with recurrence of prostate cancer. The results of this clinical trial, led by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health, appear in the August 2005 issue of the Journal of Urology.

26 Jul 2005

Cancer survivors initiate diet, exercise, and other beneficial lifestyle changes following a cancer diagnosis

An analysis of more than 100 studies of cancer survivors shows that many survivors initiate diet, exercise, and other beneficial lifestyle changes following a cancer diagnosis, but that those who are male, older, and less educated are less likely to adopt such changes. The term "cancer survivor" refers to a person who has been diagnosed with cancer.

25 Jul 2005

Government in Ontario will pay for three new cancer drugs

Canadian Health Minister George Smitherman has announced that the government will add three new and expensive cancer-fighting drugs to the list of medications it funds.

25 Jul 2005

Potential new target for stomach cancer therapy

It started several years ago with the observation that a large group of seemingly unconnected genes were behaving differently in patients with stomach cancer.

24 Jul 2005

No single PSA level ensures safety from prostate cancer risk

Ian M. Thompson Jr., M.D., professor and chair of urology at the U T Health Science Center, is looking for a better test - or set of tests - to diagnose prostate cancer and to distinguish between cancers that will kill men if left untreated and those that will not threaten health and do not need treatment.

19 Jul 2005

Innovative new brachytherapy planning tool

The Vitesse system is being used in more than 25 hospitals worldwide to speed up planning and enable treatments to take place within a day, avoiding the need for patients to stay in a hospital overnight.

19 Jul 2005

Studies explore genetic interactions between two well-known tumor suppressor proteins, PTEN and TSC2

Two papers in the August 1 issue of Genes & Development explore the genetic interactions between two well-known tumor suppressor proteins, PTEN and TSC2.

19 Jul 2005

Radiation therapy to combat early-stage prostate cancer does not affect sexual and urinary function

Men receiving radiation therapy to combat early-stage prostate cancer are still able to achieve an erection and face a low rate of incontinence one year following treatment, according to a new study published in the July 15, 2005 issue of the International Journal of Radiation Oncology-Biology-Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.

17 Jul 2005

Prostate News and Research

Lifestyle changes may affect the progression of any type of cancer

FDA approval sought for Pfizer's new cancer drug

New prostate cancer test could save thousands from unnecessary surgery

Checkerboard Tissue Microarray (TMA) Method will help in predicting the behaviour of prostate cancer

Researchers identify protein called EMP-1 that is present in the tumors of patients who fail to respond to treatment with gefitinib

Researchers use diffusion magnetic resonance imaging to monitor ultrasound uterine

Scientist have found an unexpected effect of the interaction of PTEN and p53 genes in early stage prostate cancer

Lowering the current PSA threshold for recommending a prostate biopsy may subject millions of men to unnecessary, potentially harmful medical procedures

Omega-6 fatty acids promote the growth of prostate tumor cells in the laboratory

Clinical factors can help predict the risk of prostate cancer death for patients following a radical prostatectomy

Rate of increase in PSA value predicts risk of death following radiation therapy

Tool helps determine who is at high risk of death after prostate cancer recurrence following surgery

Cancer vaccine combined with hormone-deprivation therapy can help patients with recurrence of prostate cancer

Cancer survivors initiate diet, exercise, and other beneficial lifestyle changes following a cancer diagnosis

Government in Ontario will pay for three new cancer drugs

Potential new target for stomach cancer therapy

No single PSA level ensures safety from prostate cancer risk

Innovative new brachytherapy planning tool

Studies explore genetic interactions between two well-known tumor suppressor proteins, PTEN and TSC2

Radiation therapy to combat early-stage prostate cancer does not affect sexual and urinary function

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News